Analyses of treatment outcome according to age in patients with chronic myeloid leukemia receiving imatinib frontline
Conclusions The best clinical outcomes have middle aged patients in terms of the highest rates of achievement of optimal therapeutic response and longer survival without events and longer overall survival.
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research
More News: Chronic Leukemia | Chronic Myeloid Leukaemia | Gleevec | Hematology | Leukemia | Lymphoma | Myeloma | Study